Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): A randomized controlled trial

European Journal of Neurology

Volumn 15, Issue 12, 2008, Pages 1345-1352

  Kasper, J ^a   Kopke S ^a   Muhlhauser I ^a   Nubling M ^b   Heesen, C ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b Empirical Consulting   (Germany)

Author keywords

Decision aid; Decision support techniques; Evidence based medicine; Immunotherapy; Multiple sclerosis; Patient education; Patient participation

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONSULTATION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; EVALUATION; FEMALE; GERMANY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DATA INTERPRETATION, STATISTICAL; DECISION SUPPORT TECHNIQUES; FEMALE; GERMANY; HUMANS; IMMUNOTHERAPY; INFORMED CONSENT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS;

EID: 56049122722     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02313.x     Document Type: Article

References (24)

1. Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? British Medical Journal 1999 319 : 780 782.
2. O'Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Systematic Review 2003 CD001431.
3. Filippini G, Munari L, Incorvaia B, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003 361 : 545 552.
4. Pittock SJ, Weinshenker BG, Noseworthy JH, et al. Not every patient with multiple sclerosis should be treated at time of diagnosis. Archives of Neurology 2006 63 : 611 614.
5. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annals of Neurology 2000 47 : 707 717.
6. Rice GP, Incorvaia B, Munari L, et al. Interferon in relapsing-remitting multiple sclerosis. Cochrane Database Systemic Review 2001 CD002002.
7. Clerico M, Barbero P, Contessa G, Ferrero C, Durelli L. Adherence to interferon-beta treatment and results of therapy switching. Journal of the Neurological Sciences 2007 259 : 104 108.
8. Heesen C. ISRCTN25267500: Informed Shared Decision Making In Multiple Sclerosis Immunotherapy (ISDIMS). A randomised controlled trial to investigate the effects of an evidence-based decision aid on decision-making about immunotherapy in multiple sclerosis, 2004. http://controlled-trials.com/ ISRCTN25267500 (accessed 16/09/2008).
9. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Canadian Journal of Nursing Research 1997 29 : 21 43.
10. Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. British Medical Journal 2006 333 : 417.
11. Coulter A. Paternalism or partnership? Patients have grown up - and there's no going back. British Medical Journal 1999 319 : 719 720.
12. Heesen C, Kasper J, Segal J, Köpke S, Mühlhauser I. Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis. Multiple Sclerosis 2004 10 : 643 650.
13. Kasper J, Köpke S, Mühlhauser I, Heesen C. Evidence-based patient information about treatment of multiple sclerosis - a phase one study on comprehension and emotional responses. Patient Education Counselling 2006 62 : 56 63.
14. UKMRC United Kingdom Medical Research Council. http://www.mrc.ac.uk/ Utilities/Documentrecord/index.htm?d=MRC003372.2000 (accessed 20/08/2007).
15. Kiesler DJ, Auerbach S. Optimal matches of patient preferences for information, decision-making and interpersonal behaviour: evidence, models and interventions. Patient Education Counselling 2006 61 : 319 341.
16. Hack TF, Degner LF, Dyck DG. Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Social Science and Medicine 1994 39 : 279 289.
17. Cegala DJ. Patient communication skills training: a review with implications for cancer patients. Patient Education Counselling 2003 50 : 91 94.
18. Post DM, Cegala DJ, Miser WF. The other half of the whole: teaching patients to communicate with physicians. Family Medicine 2002 34 : 344 352.
19. Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Annals of Internal Medicine 1985 102 : 520 528.
20. Hamann J, Neuner B, Kasper J, et al. Participation preferences of patients with acute and chronic conditions. Health Expect 2007 10 : 358 363.
21. Adair G. The Hawthorne effect: a reconsideration of the methodological artifact. Journal of Applied Psychology 1984 69 : 334 345.
22. Köpke S, Kasper J, Nübling M, Mühlhauser I, Heesen C. Patient education programme to enhance decision autonomy in multiple sclerosis relapse management: a randomised controlled trial. Multiple Scleroses 2008, in press.
23. Lenz M, Kasper J. MATRIX - development and feasibility of a guide for quality assessment of patient decision aids. GMS Psychosocial Medicine 2007 4 : Doc10.
24. Kennedy AD. On what basis should the effectiveness of decision aids be judged? Health Expect 2003 6 : 255 268.